Related Experiment Videos
Can Excess Glucocorticoid, Predispose to Cardiovascular and Metabolic Disease in Middle Age?
1Howard Florey Institute of Experimental Physiology and Medicine University of Melbourne, Parkville, Victoria 3052, Australia.
Insights
Maternal stress and fetal exposure to excess glucocorticoids can permanently program offspring for adult cardiovascular and metabolic diseases. Understanding these developmental programming effects is crucial for preventing long-term health issues.
Area of Science:
- Endocrinology
- Developmental Biology
- Perinatal Medicine
Background:
- Studies link offspring behavior changes to maternal stress or fetal glucocorticoid exposure.
- Epidemiological data strongly suggests in utero growth retardation is a risk factor for adult cardiovascular and metabolic diseases.
Purpose of the Study:
- To investigate the role of fetal exposure to excess glucocorticoids as a key determinant of long-term health.
- To understand the mechanisms of developmental programming by glucocorticoids.
Main Methods:
- Utilized animal models (sheep) to study the effects of early pregnancy glucocorticoid exposure.
- Administered dexamethasone for a brief period (48 hours) early in gestation.
Main Results:
- Demonstrated that even brief fetal dexamethasone exposure can permanently program hypertensive adult sheep.
- Established a direct link between early-life glucocorticoid exposure and later-life cardiovascular programming.
Conclusions:
- Fetal exposure to excess glucocorticoids is a critical factor in developmental programming of adult diseases.
- Early-life endocrine disruption can lead to lasting physiological changes and increased disease risk.
- Further research into these programming mechanisms is essential in endocrinology and developmental biology.
Abstract:
For many years, both human and animal studies correlated changes in behaviour of the young offspring with the degree of maternal stress or glucocorticoid exposure of the foetus/neonate. In the past ten years there has been overwhelming epidemiological evidence to suggest that growth retardation in utero is a very important risk factor for the development of cardiovascular and metabolic disease in adult life. More recently, it has been shown that one important, even key, determinant is the exposure of the foetus to excess glucocorticoid. Even a brief period (48 h) of dexamethasone exposure very early in pregnancy was able to programme permanently hypertensive adult sheep. Understanding how such programming works, and the underlying physiological changes that occur, provides one of the most exciting challenges in contemporary endocrinology and developmental biology.